AMEX · Biotechnology

Impact BioMedical, Inc. (IBO)

$0.46 -0.68%
76 Overbought Daily RSI (14)

Moving averages

SMA 200$0.52-11.92%

Company profile

Impact BioMedical, Inc. is an innovative biotechnology company focused on developing groundbreaking therapeutics and technologies to address critical healthcare challenges. Utilizing advanced research methodologies, the firm aims to improve patient outcomes and overall quality of life. With a robust intellectual property portfolio and an emphasis on scientific rigor, Impact BioMedical is well-positioned for growth in the evolving healthcare market. Its extensive product pipeline and strategic collaborations offer attractive investment opportunities for institutional investors interested in the accelerating biopharmaceutical sector.

SectorHealthcare
IndustryBiotechnology
Market cap$49.52M
P/E ratio0.522
EPS$0.88
BetaNone
Dividend yield0.00%
52-week high$0.83
52-week low$0.37

Similar stocks in Biotechnology

Free forever

RSI alerts for IBO

Get an email the moment Impact BioMedical, Inc. crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 16 August 2026 at 2:52 AM EDT